CDH1 and breast ductal adenocarcinoma: E-cadherin is currently used to differentiate between lobular carcinomas, without immunohistochemical expression of E-cadherin, and ductal carcinomas, which express cytoplasmic E-cadherin, in cases with non-specific morphological characteristics [43].